ADGC Publications

Found 71 results
Filters: Author is Schellenberg, Gerard D  [Clear All Filters]
2019
Choi KYeong, Lee JJae, Gunasekaran TIniyan, Kang S, Lee W, Jeong J, Lim HJae, Zhang X, Zhu C, Won S-Y et al..  2019.  Promoter Polymorphism-219T/G is an Effect Modifier of the Influence of ε4 on Alzheimer's Disease Risk in a Multiracial Sample.. J Clin Med. 8(8)
Zhang X, Zhu C, Beecham G, Vardarajan BN, Ma Y, Lancour D, Farrell JJ, Chung J, Mayeux R, Haines JL et al..  2019.  A rare missense variant of CASP7 is associated with familial late-onset Alzheimer's disease.. Alzheimers Dement. 15(3):441-452.
Dumitrescu L, Barnes LL, Thambisetty M, Beecham G, Kunkle B, Bush WS, Gifford KA, Chibnik LB, Mukherjee S, De Jager PL et al..  2019.  Sex differences in the genetic predictors of Alzheimer's pathology.. Brain. 142(9):2581-2589.
Leung YYee, Valladares O, Chou Y-F, Lin H-J, Kuzma AB, Cantwell L, Qu L, Gangadharan P, Salerno WJ, Schellenberg GD et al..  2019.  VCPA: genomic variant calling pipeline and data management tool for Alzheimer's Disease Sequencing Project.. Bioinformatics. 35(11):1985.
2018
Rajabli F, Feliciano BE, Celis K, Hamilton-Nelson KL, Whitehead PL, Adams LD, Bussies PL, Manrique CP, Rodriguez A, Rodriguez V et al..  2018.  Ancestral origin of ApoE ε4 Alzheimer disease risk in Puerto Rican and African American populations.. PLoS Genet. 14(12):e1007791.
Bonham LW, Karch CM, Fan CC, Tan C, Geier EG, Wang Y, Wen N, Broce IJ, Li Y, Barkovich MJ et al..  2018.  CXCR4 involvement in neurodegenerative diseases.. Transl Psychiatry. 8(1):73.
Broce I, Karch CM, Wen N, Fan CC, Wang Y, Tan CHong, Kouri N, Ross OA, Höglinger GU, Müller U et al..  2018.  Immune-related genetic enrichment in frontotemporal dementia: An analysis of genome-wide association studies.. PLoS Med. 15(1):e1002487.
Chen P, Guarino PD, Dysken MW, Pallaki M, Asthana S, Llorente MD, Love S, Vertrees JE, Schellenberg GD, Sano M.  2018.  Neuropsychiatric Symptoms and Caregiver Burden in Individuals With Alzheimer's Disease: The TEAM-AD VA Cooperative Study.. J Geriatr Psychiatry Neurol. 31(4):177-185.
Sanchez-Contreras MY, Kouri N, Cook CN, Serie DJ, Heckman MG, Finch NCA, Caselli RJ, Uitti RJ, Wszolek ZK, Graff-Radford N et al..  2018.  Replication of progressive supranuclear palsy genome-wide association study identifies SLCO1A2 and DUSP10 as new susceptibility loci.. Mol Neurodegener. 13(1):37.
Deming Y, Dumitrescu L, Barnes LL, Thambisetty M, Kunkle B, Gifford KA, Bush WS, Chibnik LB, Mukherjee S, De Jager PL et al..  2018.  Sex-specific genetic predictors of Alzheimer's disease biomarkers.. Acta Neuropathol. 136(6):857-872.
Bis JC, Jian X, Kunkle BW, Chen Y, Hamilton-Nelson KL, Bush WS, Salerno WJ, Lancour D, Ma Y, Renton AE et al..  2018.  Whole exome sequencing study identifies novel rare and common Alzheimer's-Associated variants involved in immune response and transcriptional regulation.. Mol Psychiatry.
2017
Höglinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang AE, Mollenhauer B, Müller U, Nilsson C, Whitwell JL et al..  2017.  Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria.. Mov Disord. 32(6):853-864.
Huang K-L, Marcora E, Pimenova AA, Di Narzo AF, Kapoor M, Jin SChih, Harari O, Bertelsen S, Fairfax BP, Czajkowski J et al..  2017.  A common haplotype lowers PU.1 expression in myeloid cells and delays onset of Alzheimer's disease.. Nat Neurosci. 20(8):1052-1061.
Gerstenecker A, Roberson ED, Schellenberg GD, Standaert DG, Shprecher DR, Kluger BM, Litvan I.  2017.  Genetic influences on cognition in progressive supranuclear palsy.. Mov Disord. 32(12):1764-1771.
Yokoyama JS, Karch CM, Fan CC, Bonham LW, Kouri N, Ross OA, Rademakers R, Kim J, Wang Y, Höglinger GU et al..  2017.  Shared genetic risk between corticobasal degeneration, progressive supranuclear palsy, and frontotemporal dementia.. Acta Neuropathol. 133(5):825-837.
2016
Allen M, Burgess JD, Ballard T, Serie D, Wang X, Younkin CS, Sun Z, Kouri N, Baheti S, Wang C et al..  2016.  Gene expression, methylation and neuropathology correlations at progressive supranuclear palsy risk loci.. Acta Neuropathol. 132(2):197-211.
Guarino PD, Vertrees JE, Asthana S, Sano M, Llorente MD, Pallaki M, Love S, Schellenberg GD, Dysken MW.  2016.  Measuring informed consent capacity in an Alzheimer's disease clinical trial.. Alzheimers Dement (N Y). 2(4):258-266.
2015
Kouri N, Ross OA, Dombroski B, Younkin CS, Serie DJ, Soto-Ortolaza A, Baker M, Finch NCole A, Yoon H, Kim J et al..  2015.  Genome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsy.. Nat Commun. 6:7247.
Wheeler JM, McMillan PJ, Hawk M, Iba M, Robinson L, Xu GJ, Dombroski BA, Jeong D, Dichter MA, Juul H et al..  2015.  High copy wildtype human 1N4R tau expression promotes early pathological tauopathy accompanied by cognitive deficits without progressive neurofibrillary degeneration.. Acta Neuropathol Commun. 3:33.
2014
Sud R, Geller ET, Schellenberg GD.  2014.  Antisense-mediated Exon Skipping Decreases Tau Protein Expression: A Potential Therapy For Tauopathies.. Mol Ther Nucleic Acids. 3:e180.
Dysken MW, Sano M, Asthana S, Vertrees JE, Pallaki M, Llorente M, Love S, Schellenberg GD, J McCarten R, Malphurs J et al..  2014.  Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trial.. JAMA. 311(1):33-44.
Samocha KE, Robinson EB, Sanders SJ, Stevens C, Sabo A, McGrath LM, Kosmicki JA, Rehnström K, Mallick S, Kirby A et al..  2014.  A framework for the interpretation of de novo mutation in human disease.. Nat Genet. 46(9):944-50.
McMillan CT, Toledo JB, Avants BB, Cook PA, Wood EM, Suh ER, Irwin DJ, Powers J, Olm C, Elman L et al..  2014.  Genetic and neuroanatomic associations in sporadic frontotemporal lobar degeneration.. Neurobiol Aging. 35(6):1473-82.
Borenstein AR, Wu Y, Bowen JD, McCormick WC, Uomoto J, McCurry SM, Schellenberg GD, Larson EB.  2014.  Incidence rates of dementia, Alzheimer disease, and vascular dementia in the Japanese American population in Seattle, WA: the Kame Project.. Alzheimer Dis Assoc Disord. 28(1):23-9.
Warmus BA, Sekar DR, McCutchen E, Schellenberg GD, Roberts RC, McMahon LL, Roberson ED.  2014.  Tau-mediated NMDA receptor impairment underlies dysfunction of a selectively vulnerable network in a mouse model of frontotemporal dementia.. J Neurosci. 34(49):16482-95.

Pages